Yang L et al. identified that the disruption of the CD24-Siglec-E interaction exacerbates metabolic disorders associated with obesity, while therapy involving CD24Fc shows improvement (26). This evidence concerns the gene CD24 and obesity due to melanocortin 4 receptor deficiency.